Coronavirus: “The Russian vaccine produces antibodies.” Lancet writes it

The vaccine announced by Vladimir Putin, the object of so much irony on social networks and the raised frown of the WHO, seems “to have the ability to produce anti-cover, without major side effects.” The prestigious scientific journal writes it Lancet.

rep

Interview

“There is an announcement about the Russian vaccine, but not the data. Science doesn’t work like that “

by ELENA DUSI

After the president’s announcements Vladimir Putin, the first scientific data arrives. Published in the Lancet, they show that 100% of the test participants developed antibodies against the SarsCov2 virus, without serious side effects. However, whichever vaccine hits the market first, it is unlikely to become widespread in the world before mid-2021, warns the World Health Organization (WHO).

rep

Deepening

Selling the cure to the world: Moscow wants to get to the post-Covid business first

by Federico Rampini

“We do not expect to see widespread vaccination until the middle of next year,” the WHO spokesman said. Margaret Harris. “This phase 3 takes longer because we need to see how protective the vaccine really is and how safe it is,” he added. A prediction also shared by the editor of the Lancet, Richard Horton, according to which “although there are many candidates, we can expect at least one vaccine in the first months of 2021”, but this “will not be immediately available to everyone”.

The first data on Russian indicates the production of an immune response in the 76 volunteers, healthy adults between 18 and 60 years old, involved in phases 1 and 2 of the experiment. Two different human adenoviruses are used, that is, one of the viruses that cause colds, modified to carry the gene for the Spike protein, which allows the coronavirus to enter human cells.

The positive result, notes the virologist. Carlo Federico Bolt, director of the Microbiology unit at the Bambino Gesù Hospital in Rome, “is that the results on the vaccine that until now had only been announced in the newspapers by Russian politicians have finally been published in a scientific journal.” And adds the virologist Giorgio Palù from the University of Padua, “the Russian vaccine appears to be on par with others that are being tested in the world.” However, the “fundamental data of phase 3 -concludes Perno- is still missing, that is, the one carried out on thousands of people, which serves to check whether who has been vaccinated or who has not been more infected.” A total of 164 candidate vaccines are being studied, of which 25 are being tested in humans and 5 have reached phase 3 of the tests, the most advanced.